Neurogene
Danielle Boyle has a diverse work experience in the field of quality assurance. Danielle'smost recent role was as a Manager of Quality Assurance at Neurogene Inc. starting in June 2023. Prior to that, they worked as a QA Specialist at the same company from May 2021 to June 2023.
Before joining Neurogene Inc., Danielle worked at Lonza from 2016 to 2021, where they held various roles including Quality Assurance Project Lead IV, Quality Assurance Specialist III, and Quality Assurance Specialist II.
Prior to their experience at Lonza, Danielle worked as a Quality Assurance Analyst at Apex International Mfg, Inc. from 2014 to 2016.
Danielle also has experience as a QA Lab Technician (Contract) at Agropur in 2013 and as a Lab Assistant at MaryPaul Laboratories Inc. in 2012.
Danielle's career began as a Microbiology Intern at Rutgers University in 2011, where they gained skills in running PCR's, gel electrophoresis, isolating plasmids, and performing transformations with E. coli to study plasmid function.
Danielle Boyle completed their education at Sussex County Community College from 2006 to 2008, where they obtained an Associates of Science degree in Biology. Following this, they attended Rutgers University from 2008 to 2011, where they earned a Bachelors of Science degree in Microbiology with a minor in Biochemistry.
This person is not in any offices
Neurogene
Neurogene was founded to bring life-changing medicines to patients and families affected by rare neurological disorders. We partner with leading academic researchers, patient advocacy organizations and caregivers to bring to patients therapies that address the underlying genetic cause of a broad spectrum of neurological diseases where no effective treatment options exist today. Our lead programs use AAV-based gene therapy technology to deliver a normal gene to patients with a dysfunctional gene. Neurogene is also investing in novel technology to develop treatments for diseases not well served by gene therapy.